Semiconductor DNA
Semiconductor IC Design Model
Applied to In-Vitro Diagnostics
First-in-class BioFabless Design House
Inspired by the fabless semiconductor paradigm, we develop and own 100% of our silicon IP and focus on chip design excellence. As a direct customer of UMC, a leading semiconductor foundry in Taiwan, we maintain the flexibility to rapidly iterate chip designs while leveraging the cost advantages of mature-node manufacturing on 8-inch wafers.
Our analogue ASIC is built on extended-gate FET (EG-FET) architecture and purpose-designed for ultra-sensitive biomarker detection at low concentrations and high-performance molecular diagnostics in real-world clinical settings.
100% Silicon IP Built from Ground Up
Different from many IC design houses that rely heavily on standard IP blocks and automated EDA (Electric Design Automation) tool flows, we have developed our own silicon IP. This allows us to preserve both performance differentiation and capture full economic value.
Novascope’s BioIC Platform: Robustness, Scalability and Cost Efficiency
NS01C: FET-Based Biosensing with Intrinsic Control & Multiplexing
NS01C is our field-effect transistor (FET) biosensing architecture designed specifically for surface-charge detection of an assay with up to eight target molecules. When a target analyte binds to a probe embedded on the chip surface, it alters the local electric field and converts molecular binding events into measurable electronic signals in real time.
All our products currently in the pipeline are built on NS01C.
NS02A: Array Sensor Architecture for High-Throughput Detection
NS02A expands the NovaChip platform into a high-density array configuration, enabling scalable multiplexing and quantitative analysis across large biomarker panels. The NS02A architecture is particularly suited for pathogen panels and antimicrobial resistance (AMR) profiling, where simultaneous interrogation of multiple genetic markers is essential for timely clinical decision-making.
NS03A: Photoelectric Sensor for Hybrid Detection Modalities
NS03A introduces a complementary photoelectric sensing module to support hybrid detection strategies. While Novascope’s core platform leverages electronic charge redistribution, NS03A takes a step further to enable optical-electronic integration where fluorescence or photonic signals can enhance assay flexibility.
Billions of Probe Sensors Packed into One Biochip
Request Investor Deck : ir@novascopedx.com
Novascope is a semiconductor-driven biotech company developing ultra-sensitive biochips for rapid, early disease detection and precision diagnostics
© 2026 Novascope Diagnostics Inc.